blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1355660

EP1355660 - COMPOSITION AND KIT FOR USE IN THE TREATMENT OF TUMORS [Right-click to bookmark this link]
Former [2003/44]THERAPEUTIC MODULATION OF THE TUMOR INFLAMMATORY RESPONSE
[2006/32]
StatusNo opposition filed within time limit
Status updated on  30.05.2008
Database last updated on 22.05.2024
Most recent event   Tooltip25.02.2011Lapse of the patent in a contracting state
New state(s): IT		published on 30.03.2011  [2011/13]
Applicant(s)For all designated states
Biother Corporation
8027 Oakington Drive
Houston, TX 77071 / US
[2003/44]
Inventor(s)01 / ROUSSEL, Eugene
8027 Oakington Drive
Houston, TX 77071 / US
 [2003/44]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[N/P]
Former [2003/44]Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
Maximilianstrasse 58
80538 München / DE
Application number, filing date02720778.609.01.2002
[2003/44]
WO2002US00749
Priority number, dateUS2001075697809.01.2001         Original published format: US 756978
[2003/44]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO02055024
Date:18.07.2002
Language:EN
[2002/29]
Type: A2 Application without search report 
No.:EP1355660
Date:29.10.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 18.07.2002 takes the place of the publication of the European patent application.
[2003/44]
Type: B1 Patent specification 
No.:EP1355660
Date:25.07.2007
Language:EN
[2007/30]
Search report(s)International search report - published on:US27.02.2003
(Supplementary) European search report - dispatched on:EP29.04.2004
ClassificationIPC:A61K38/43, A61K38/49, A61K39/00, A61K39/38
[2003/44]
CPC:
A61K38/212 (EP,US); A61K45/06 (EP,US); A61P35/00 (EP);
A61P37/04 (EP)
C-Set:
A61K38/212, A61K2300/00 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/44]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:ZUSAMMENSETZUNG UND KIT ZUR VERWENDUNG IN DER TUMORBEHANDLUNG[2006/32]
English:COMPOSITION AND KIT FOR USE IN THE TREATMENT OF TUMORS[2006/32]
French:COMPOSITION ET KIT POUR LEUR UTILISATION DANS LE TRAITEMENT DES TUMEURS[2006/32]
Former [2003/44]THERAPEUTISCHE MODULATION DER INFLAMMATORISCHEN TUMORREAKTION
Former [2003/44]THERAPEUTIC MODULATION OF THE TUMOR INFLAMMATORY RESPONSE
Former [2003/44]MODULATION THERAPEUTIQUE DE LA REACTION INFLAMMATOIRE DE TUMEURS
Entry into regional phase05.08.2003National basic fee paid 
05.08.2003Search fee paid 
05.08.2003Designation fee(s) paid 
05.08.2003Examination fee paid 
Examination procedure05.08.2003Amendment by applicant (claims and/or description)
05.08.2003Examination requested  [2003/44]
27.01.2005Despatch of a communication from the examining division (Time limit: M04)
06.06.2005Reply to a communication from the examining division
18.07.2005Despatch of a communication from the examining division (Time limit: M04)
28.11.2005Reply to a communication from the examining division
04.07.2006Date of oral proceedings
18.07.2006Minutes of oral proceedings despatched
16.08.2006Communication of intention to grant the patent
20.12.2006Fee for grant paid
20.12.2006Fee for publishing/printing paid
Divisional application(s)EP06013748.6  / EP1769805
Opposition(s)28.04.2008No opposition filed within time limit [2008/27]
Fees paidRenewal fee
30.01.2004Renewal fee patent year 03
12.01.2005Renewal fee patent year 04
12.01.2006Renewal fee patent year 05
31.05.2007Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.01.200706   M06   Fee paid on   31.05.2007
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT25.07.2007
CY25.07.2007
DK25.07.2007
FI25.07.2007
NL25.07.2007
TR25.07.2007
SE25.10.2007
GR26.10.2007
PT26.12.2007
LU09.01.2008
IT31.01.2008
MC31.01.2008
[2011/13]
Former [2010/37]AT25.07.2007
CY25.07.2007
DK25.07.2007
FI25.07.2007
NL25.07.2007
TR25.07.2007
SE25.10.2007
GR26.10.2007
PT26.12.2007
LU09.01.2008
MC31.01.2008
Former [2010/32]AT25.07.2007
CY25.07.2007
DK25.07.2007
FI25.07.2007
NL25.07.2007
SE25.10.2007
GR26.10.2007
PT26.12.2007
LU09.01.2008
MC31.01.2008
Former [2009/33]AT25.07.2007
CY25.07.2007
DK25.07.2007
FI25.07.2007
NL25.07.2007
SE25.10.2007
GR26.10.2007
PT26.12.2007
MC31.01.2008
Former [2008/40]AT25.07.2007
DK25.07.2007
FI25.07.2007
NL25.07.2007
SE25.10.2007
GR26.10.2007
PT26.12.2007
MC31.01.2008
Former [2008/28]AT25.07.2007
DK25.07.2007
FI25.07.2007
NL25.07.2007
SE25.10.2007
GR26.10.2007
PT26.12.2007
Former [2008/22]AT25.07.2007
DK25.07.2007
FI25.07.2007
NL25.07.2007
GR26.10.2007
PT26.12.2007
Former [2008/13]AT25.07.2007
FI25.07.2007
NL25.07.2007
PT26.12.2007
Former [2008/10]FI25.07.2007
NL25.07.2007
PT26.12.2007
Former [2008/09]NL25.07.2007
Documents cited:Search[X]US4879111  (CHONG KONG-TECK [US]) [X] 1,2,4 * example 3 *;
 [XY]US5082658  (PALLADINO MICHAEL A [US]) [X] 1-3,26,49,50,53-61 * column 1, lines 39-55 * [Y] 1-61;
 [Y]US5446033  (ENGEL JUERGEN [DE], et al) [Y] 1-61 * claim 11 *;
 [Y]US5474981  (LEDER PHILIP [US], et al) [Y] 1-61 * claim - *;
 [Y]US5871723  (STRIETER ROBERT M [US], et al) [Y] 1-61 * claims 19,20,24,29 *;
 [Y]WO9959599  (MEDMARK PHARMA GMBH [DE], et al) [Y] 1-61 * page 1, lines 6-9; claim - *;
 [Y]WO0001392  (MEDMARK PHARMA GMBH [DE], et al) [Y] 1-61 * page 4, lines 7-23; claim - *;
 [PY]WO0162274  (INST CIENTIFICO TECNOL NAVARRA [ES], et al) [PY] 1-61 * the whole document ** abstract *;
 [Y]  - SVEDERSKY L P ET AL, "ENHANCED ANTITUMOR ACTIVITY OF RECOMBINANT INTERFERON GAMMA IN COMBINATION WITH TUMOR NECROSIS FACTORS AND CHEMOTHERAPEUTIC AGENTS", INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 3RD INTERNATIONAL CONFERENCE ON IMMUNOPHARMACOLOGY, FLORENCE, ITALY, MAY 6-9, 1985. INT J IMMUNOPHAR, (1985), vol. 7, no. 3, ISSN 0192-0561, page 330, XP001180838 [Y] 1-61 * the whole document *

DOI:   http://dx.doi.org/10.1016/0192-0561(85)90260-7
International search[Y]  - MORI ET AL., "Interaction of interon gamma and CPT-11, a new derivative of camptothecin, in human endometrial carcinoma cell lines", INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, (199301), vol. 3, no. 1, pages 36 - 43, XP002958192

DOI:   http://dx.doi.org/10.1046/j.1525-1438.1993.03010036.x
 [Y]  - AKATOV ET AL., "Combined vitamins B12b and C induce the glutathione depletion and the death of epidermoid human larynx carcinoma cells HEp-2", BIOSCIENCE REPORTS, (200010), vol. 20, no. 5, pages 411 - 417, XP002959218

DOI:   http://dx.doi.org/10.1023/A:1010386102562
 [Y]  - SCHRAUZER, "Anticarcinogenic effects of selenium", CELLULAR AND MOLECULAR LIFE SCIENCE, (200012), vol. 57, no. 13-14, pages 1864 - 1873, XP002958194
 [Y]  - ZEISIG ET AL., "Cytotoxic effects of alkylphosphocholines or alkylphosphocholine-liposomes and macrophages of tumor cells", ANTICANCER RESEARCH, (199409), vol. 14, no. 5A, pages 1785 - 1789, XP002958193
 [Y]  - WUYTS ET AL., "Leukocyte recruitment by monocyte chemotactic proteins (MPCs) secreted by human phagocytes", JOURNAL IMMUNOLOGICAL METHODS, (199409), vol. 174, no. 1-2, pages 237 - 247, XP002042707

DOI:   http://dx.doi.org/10.1016/0022-1759(94)90028-0
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.